<code id='9F20A047B0'></code><style id='9F20A047B0'></style>
    • <acronym id='9F20A047B0'></acronym>
      <center id='9F20A047B0'><center id='9F20A047B0'><tfoot id='9F20A047B0'></tfoot></center><abbr id='9F20A047B0'><dir id='9F20A047B0'><tfoot id='9F20A047B0'></tfoot><noframes id='9F20A047B0'>

    • <optgroup id='9F20A047B0'><strike id='9F20A047B0'><sup id='9F20A047B0'></sup></strike><code id='9F20A047B0'></code></optgroup>
        1. <b id='9F20A047B0'><label id='9F20A047B0'><select id='9F20A047B0'><dt id='9F20A047B0'><span id='9F20A047B0'></span></dt></select></label></b><u id='9F20A047B0'></u>
          <i id='9F20A047B0'><strike id='9F20A047B0'><tt id='9F20A047B0'><pre id='9F20A047B0'></pre></tt></strike></i>

          knowledge

          knowledge

          author:fashion    Page View:644

          Has AI really solved biology? What can machines teach us about medicine? And what’s a digital twin?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. It’s our all-AI episode. First, STAT’s Casey Ross joins us to explain his reporting on how researchers and pharmaceutical firms are using the technology to find new drug targets, design therapies, and improve clinical trials. Then, we talk to Joel Dudley, a partner at the venture firm Innovation Endeavors, about how to discern promising ideas from wastes of time when it comes to AI in biotech.

          advertisement

          For more on what we cover, here’s the latest on AI in drug development; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          advertisement

          knowledge

          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more
          Stroke deaths set to near 10 million globally by 2050
          Stroke deaths set to near 10 million globally by 2050

          AdobeThenumberofstrokedeathsworldwideissettoclimb50%tonearly10millionby2050,withmostcasesoccurringin

          read more
          Heart attack and stroke risk calculators need revising
          Heart attack and stroke risk calculators need revising

          AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

          read more

          Crinetics acromegaly drug succeeds in late

          AresearcherworkinginthelabatCrineticsPharmaceuticalsinSanDiego.CourtesyCrineticsSANDIEGO—CrineticsPh